1. Home
  2. CHEK vs BCAN Comparison

CHEK vs BCAN Comparison

Compare CHEK & BCAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • BCAN
  • Stock Information
  • Founded
  • CHEK 2004
  • BCAN 2019
  • Country
  • CHEK Israel
  • BCAN Israel
  • Employees
  • CHEK N/A
  • BCAN N/A
  • Industry
  • CHEK Medical Electronics
  • BCAN Computer Software: Prepackaged Software
  • Sector
  • CHEK Health Care
  • BCAN Technology
  • Exchange
  • CHEK Nasdaq
  • BCAN Nasdaq
  • Market Cap
  • CHEK 5.1M
  • BCAN 5.3M
  • IPO Year
  • CHEK 2015
  • BCAN N/A
  • Fundamental
  • Price
  • CHEK $0.61
  • BCAN $8.07
  • Analyst Decision
  • CHEK
  • BCAN
  • Analyst Count
  • CHEK 0
  • BCAN 0
  • Target Price
  • CHEK N/A
  • BCAN N/A
  • AVG Volume (30 Days)
  • CHEK 14.0K
  • BCAN 4.0K
  • Earning Date
  • CHEK 02-14-2025
  • BCAN 01-01-0001
  • Dividend Yield
  • CHEK N/A
  • BCAN N/A
  • EPS Growth
  • CHEK N/A
  • BCAN N/A
  • EPS
  • CHEK N/A
  • BCAN N/A
  • Revenue
  • CHEK N/A
  • BCAN $754,768.00
  • Revenue This Year
  • CHEK N/A
  • BCAN N/A
  • Revenue Next Year
  • CHEK N/A
  • BCAN N/A
  • P/E Ratio
  • CHEK N/A
  • BCAN N/A
  • Revenue Growth
  • CHEK N/A
  • BCAN N/A
  • 52 Week Low
  • CHEK $0.61
  • BCAN $7.70
  • 52 Week High
  • CHEK $3.45
  • BCAN $1,776.50
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 19.96
  • BCAN 50.13
  • Support Level
  • CHEK $0.61
  • BCAN $7.88
  • Resistance Level
  • CHEK $0.83
  • BCAN $8.64
  • Average True Range (ATR)
  • CHEK 0.04
  • BCAN 0.16
  • MACD
  • CHEK -0.00
  • BCAN 0.01
  • Stochastic Oscillator
  • CHEK 0.44
  • BCAN 32.14

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About BCAN BYND Cannasoft Enterprises Inc.

Femto Technologies Inc is an integrated software company. It owns and markets Benefit CRM, a proprietary customer relationship management CRM software product enabling small and medium sized businesses to optimize their day to day business activities such as sales management, personnel management, marketing, call center activities, and asset management.

Share on Social Networks: